NCT04370028View on ClinicalTrials.gov

Study on Efficacy and Safety of Divaza in Patients With Chronic Cerebral Ischemia and Cognitive Disorders

CompletedOBSERVATIONAL
Enrollment

2,583

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Chronic Cerebral Ischemia
Interventions
DRUG

Divaza

Oral administration.

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT04370028 - Study on Efficacy and Safety of Divaza in Patients With Chronic Cerebral Ischemia and Cognitive Disorders | Biotech Hunter | Biotech Hunter